Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

The study found that the number of advanced therapy Phase I trials in the UK nearly doubled since the same time in 2023.

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...

Budget 2025 hopes to extend financial incentives to clinical research industry for developing cutting-edge therapies in India ...

The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

Over the past month the first cohort of participants have undergone sessions with mushroom extract containing a specific dose ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...